Evaluation of rucaparib in platinum-sensitive recurrent ovarian carcinoma (rOC) in patients (pts) with or without residual bulky disease at baseline in the ARIEL3 study Meeting Abstract
| Authors: | Aghajanian, C.; Coleman, R. L.; Oza, A. M.; Lorusso, D.; Oaknin, A.; Dean, A. P.; Colombo, N.; Weberpals, J. I.; Clamp, A. R.; Scambia, G.; Leary, A.; Holloway, R. W.; Fong, P. C.; Goh, J. C.; O'Malley, D. M.; Banerjee, S. N.; Wride, K.; Cameron, T.; Ledermann, J. A. |
| Abstract Title: | Evaluation of rucaparib in platinum-sensitive recurrent ovarian carcinoma (rOC) in patients (pts) with or without residual bulky disease at baseline in the ARIEL3 study |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 303s |
| Language: | English |
| ACCESSION: | WOS:000442916002232 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.5537 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 5537 -- Source: Wos |
